Takeaway
This international registry study found that long-term immunotherapy treatment prevent neurological disability for people with relapse-remitting multiple sclerosis (RRMS).
Why this matters
Conclusive evidence of the effect of long-term immunotherapy on multiple sclerosis (MS) related neurological disability is lacking.